A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of rituximab in combination with
chemotherapy (fludarabine and cyclophosphamide) in participants with B-cell CLL.